Skip to Main Content

School of Public Health: Anis Emilia

Researchers / חוקרים

 Last updated September 2023 - School of Public Health

List of Publications

1.

Balash Y, Kahana E, Korczyn AD, Wolker M, Nabal H, Anis E, et al. Is There Horizontal Transmission of Creutzfeldt-Jakob Disease? Neuroepidemiology [Internet]. 2023;57(3):156–61. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85168428363&doi=10.1159%252f000530407&partnerID=40&md5=99cd7dac3862ead95394908b61889ecc

2.

Anis E, Preis SA, Cedar N, Tal Y, Hershkowitz I, Hershko AY. Reporting of Allergic Reactions During Pfizer-BioNTech BNTT162B2 Vaccination in Israel. Journal of Allergy and Clinical Immunology: In Practice [Internet]. 2022;10(11):2969–76. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85136228487&doi=10.1016%252fj.jaip.2022.07.012&partnerID=40&md5=9db78af284139b5154ede661d06b8674

3.

Mevorach D, Anis E, Cedar N, Hasin T, Bromberg M, Goldberg L, et al. Myocarditis After BNT162b2 COVID-19 Third Booster Vaccine in Israel. Circulation [Internet]. 2022;146(10):802–4. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85137312715&doi=10.1161%252fCIRCULATIONAHA.122.060961&partnerID=40&md5=73be7cc0a7ab3eececae380d42f6b2a6

4.

Stein M, Grossman Z, Brosh-Nissimov T, Gottesman BS, Shahar A, Wechsler E, et al. How compassionate use enabled Israel to deliver the Pfizer-BioNTech COVID-19 vaccination to vulnerable children aged 12–15 years before regulatory approval. Acta Paediatrica, International Journal of Paediatrics [Internet]. 2022;111(4):834–41. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85122431711&doi=10.1111%252fapa.16226&partnerID=40&md5=8cd893684955f73a31fba960ab100f16

5.

Mevorach D, Anis E, Cedar N, Hasin T, Bromberg M, Goldberg L, et al. Myocarditis after BNT162b2 Vaccination in Israeli Adolescents. New England Journal of Medicine [Internet]. 2022;386(10):998–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85125778823&doi=10.1056%252fNEJMc2116999&partnerID=40&md5=996719f8ab5a9a8a36db817305963c69

6.

Haas EJ, McLaughlin JM, Khan F, Angulo FJ, Anis E, Lipsitch M, et al. Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer–BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective surveillance study. The Lancet Infectious Diseases [Internet]. 2022;22(3):357–66. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85124985960&doi=10.1016%2fS1473-3099%2821%2900566-1&partnerID=40&md5=b56e5d8b747933b066f133d909c55fb4

7.

Green MS, Peer V, Magid A, Hagani N, Anis E, Nitzan D. Gender Differences in Adverse Events Following the Pfizer-BioNTech COVID-19 Vaccine. Vaccines [Internet]. 2022;10(2). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85123981268&doi=10.3390%252fvaccines10020233&partnerID=40&md5=c4b41d47e77b3d18f5d7ee4318f96016

8.

Gorelik Y, Anis E, Edelstein M. Inequalities in initiation of COVID19 vaccination by age and population group in Israel- December 2020-July 2021. The Lancet Regional Health - Europe [Internet]. 2022;12. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85120312030&doi=10.1016%252fj.lanepe.2021.100234&partnerID=40&md5=ee11014fca233d14d9741262f055cd6e

9.

Mevorach D, Anis E, Cedar N, Bromberg M, Haas EJ, Nadir E, et al. Myocarditis after BNT162b2 mRNA vaccine against covid-19 in Israel. New England Journal of Medicine [Internet]. 2021;385(23):2140–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85120824418&doi=10.1056%252fNEJMoa2109730&partnerID=40&md5=52917fd4e218e190b5144b2ba12fbb0d

10.

Singer SR, Angulo FJ, Swerdlow DL, McLaughlin JM, Hazan I, Ginish N, et al. Effectiveness of BNT162b2 mRNA COVID-19 vaccine against SARS-CoV-2 variant Beta (B.1.351) among persons identified through contact tracing in Israel: A prospective cohort study. EClinicalMedicine [Internet]. 2021;42. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85120332320&doi=10.1016%252fj.eclinm.2021.101190&partnerID=40&md5=0ad6b410573712177c322069506e2934

11.

Anis E, Haas EJ, Indenbaum V, Singer SR, Warshavsky B, Rishpon S, et al. A prolonged, nationwide measles outbreak despite very high vaccination coverage in Israel, 2018-19. Journal of Infection [Internet]. 2021;83(6):678–85. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85117817329&doi=10.1016%252fj.jinf.2021.09.025&partnerID=40&md5=6f6852029396bf196e49573db2e0843e

12.

Netanel C, Ben-Aharon O, Ben-Ari Z, Chodick G, Anis E, Magnezi R. Evaluation of a universal hepatitis B vaccination program and antenatal screening for hepatitis B surface antigen: Results from a real-world study 2015–2016. Vaccine [Internet]. 2021;39(48):7101–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85119343034&doi=10.1016%252fj.vaccine.2021.09.072&partnerID=40&md5=a3e88adfb7e4cd13bc7f8cbc3e1acc1a

13.

Perepliotchikov Y, Ziv-Baran T, Hindiyeh M, Manor Y, Sofer D, Moran-Gilad J, et al. Inferring numbers of wild poliovirus excretors using quantitative environmental surveillance. Vaccines [Internet]. 2021;9(8). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85113309850&doi=10.3390%252fvaccines9080870&partnerID=40&md5=b2285275032610842b03d95921d5b8c9

14.

Reicher S, Ratzon R, Ben-Sahar S, Hermoni-Alon S, Mossinson D, Shenhar Y, et al. Nationwide seroprevalence of antibodies against SARS-CoV-2 in Israel. European Journal of Epidemiology [Internet]. 2021;36(7):727–34. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85104942106&doi=10.1007%252fs10654-021-00749-1&partnerID=40&md5=10aa1c8775ac3050ee81262fe70aa1f0

15.

Haas EJ, Angulo FJ, McLaughlin JM, Anis E, Singer SR, Khan F, et al. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data. The Lancet [Internet]. 2021;397(10287):1819–29. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85105784684&doi=10.1016%2fS0140-6736%2821%2900947-8&partnerID=40&md5=14bdb55677203e2b3c350535eaff51c1

16.

Gozlan Y, Bar-Or I, Volnowitz H, Asulin E, Rich R, Anis E, et al. Lessons from intensified surveillance of viral hepatitis a, Israel, 2017 and 2018. Eurosurveillance [Internet]. 2021;26(6). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85101448014&doi=10.2807%252f1560-7917.ES.2021.26.6.2000001&partnerID=40&md5=999be3a1fe171c5275d380d8263b2cc9

17.

Langsam D, Anis E, Haas EJ, Gosinov R, Yechezkel M, Grotto I, et al. Tdap vaccination during pregnancy interrupts a twenty-year increase in the incidence of pertussis. Vaccine [Internet]. 2020;38(12):2700–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080850368&doi=10.1016%252fj.vaccine.2020.01.095&partnerID=40&md5=29f323e33bcbbea4af2fdf9277bcfe84

18.

Tur-Sinai A, Gur-Arie R, Davidovitch N, Kopel E, Glazer Y, Anis E, et al. Vaccination uptake and income inequalities within a mass vaccination campaign. Israel Journal of Health Policy Research [Internet]. 2019;8(1). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85069049662&doi=10.1186%252fs13584-019-0324-6&partnerID=40&md5=60899bfacd0970914ecda923fd95e498

19.

Bercovich S, Anis E, Kassem E, Rubinstein U, Ephros M, Cohen D, et al. Validation of parental reports of rotavirus vaccination of their children compared to the national immunization registry. Vaccine [Internet]. 2019;37(21):2791–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85064254436&doi=10.1016%252fj.vaccine.2019.04.037&partnerID=40&md5=b5ebf742c120a5bda32574c375483e22

20.

Salama M, Amitai Z, Lustig Y, Mor Z, Weiberger M, Chowers M, et al. Outbreak of West Nile Virus disease in Israel (2015): A retrospective analysis of notified cases. Travel Medicine and Infectious Disease [Internet]. 2019;28:41–5. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85050107948&doi=10.1016%252fj.tmaid.2018.07.008&partnerID=40&md5=f8a0d39eaa64ea0d50a4d495bc56e3c4

21.

Lustig Y, Gosinov R, Zuckerman N, Glazer Y, Orshan L, Sofer D, et al. Epidemiologic and phylogenetic analysis of the 2018 west Nile virus (WNV) outbreak in Israel demonstrates human infection of WNV lineage I. Eurosurveillance [Internet]. 2019;24(1). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85059797012&doi=10.2807%252f1560-7917.ES.2019.24.1.1800662&partnerID=40&md5=43f4de4efbbc3ac0f9561c4cfa6ba26d

22.

Ghanem-Zoubi N, Eljay SP, Anis E, Paul M. Reemergence of human brucellosis in Israel. Israel Medical Association Journal [Internet]. 2019;21(1):10–2. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85060626108&partnerID=40&md5=055fce0f94002aca2fdb23bab3d94456

23.

Elran B, Yaari S, Glazer Y, Honovich M, Grotto I, Anis E. Parents’ perceptions of childhood immunization in Israel: Information and concerns. Vaccine [Internet]. 2018;36(52):8062–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85057025697&doi=10.1016%252fj.vaccine.2018.10.078&partnerID=40&md5=38c888ccbfa82f6dc54c02fb08d8d96e

24.

Adamker G, Holzer T, Karakis I, Amitay M, Anis E, Singer SR, et al. Prediction of Shigellosis outcomes in Israel using machine learning classifiers. Epidemiology and Infection [Internet]. 2018;146(11):1445–51. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85048129890&doi=10.1017%252fS0950268818001498&partnerID=40&md5=155f6e52cc4ae6f47484f67b90933e8b

25.

Anis E, Moerman L, Ginsberg G, Karakis I, Slater PE, Warshavsky B, et al. Did two booster doses for schoolchildren change the epidemiology of pertussis in Israel? Journal of Public Health Policy [Internet]. 2018;39(3):304–17. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85047661191&doi=10.1057%252fs41271-018-0130-3&partnerID=40&md5=af4ef7a681b9c153a442c626467f8010

26.

Rosenberg Danziger C, Anis E, Gordon ES, Grotto I, Danon YL. Reintroducing OPV in Israel on the journey to global polio eradication – Estimation at a low rate of contraindicated population. Vaccine [Internet]. 2018;36(26):3717–20. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85047076616&doi=10.1016%252fj.vaccine.2018.05.047&partnerID=40&md5=8ec1f9e570c3c8ccc6b3757a4208e743

27.

Ghanem-Zoubi N, Eljay SP, Anis E, Paul M. Association between human brucellosis and adverse pregnancy outcome: a cross-sectional population-based study. European Journal of Clinical Microbiology and Infectious Diseases [Internet]. 2018;37(5):883–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85040648094&doi=10.1007%252fs10096-017-3181-7&partnerID=40&md5=5da53f9cd3c8399651d0cd9aa81a0bc2

28.

Dadon Y, Haas EJ, Kaliner E, Anis E, Singer SR, Atiya-Nasagi Y, et al. Outbreak of human leptospirosis linked to contaminated water bodies in Northern Israel, June to August 2018. Eurosurveillance [Internet]. 2018;23(38). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85055072448&doi=10.2807%252f1560-7917.ES.2018.23.38.1800486&partnerID=40&md5=8415661e0b2d09d810d74587b2ba6586

29.

Muhsen K, Anis E, Rubinstein U, Kassem E, Goren S, Shulman LM, et al. Effectiveness of rotavirus pentavalent vaccine under a universal immunization programme in Israel, 2011–2015: a case–control study. Clinical Microbiology and Infection [Internet]. 2018;24(1):53–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85021200106&doi=10.1016%252fj.cmi.2017.04.018&partnerID=40&md5=65e7794a59f5b4842b95d2aa6a9ce482

30.

Lustig Y, Kaufman Z, Mendelson E, Orshan L, Anis E, Glazer Y, et al. Spatial distribution of West Nile virus in humans and mosquitoes in Israel, 2000–2014. International Journal of Infectious Diseases [Internet]. 2017;64:20–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85029813769&doi=10.1016%252fj.ijid.2017.08.011&partnerID=40&md5=d1e93645fff3e14bd3eaf240e48663be

31.

Indenbaum V, Hübschen JM, Stein-Zamir C, Mendelson E, Sofer D, Hindiyeh M, et al. Ongoing mumps outbreak in Israel, January to August 2017. Eurosurveillance [Internet]. 2017;22(35). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85029219476&doi=10.2807%252f1560-7917.ES.2017.22.35.30605&partnerID=40&md5=7ebdf94b2516fc0b3332f1955f04c796

32.

Gozlan Y, Bar-Or I, Rakovsky A, Savion M, Amitai Z, Sheffer R, et al. Ongoing hepatitis a among men who have sex with men (MSM) linked to outbreaks in Europe in Tel Aviv area, Israel, December 2016 – June 2017. Eurosurveillance [Internet]. 2017;22(29). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85026294731&doi=10.2807%252f1560-7917.ES.2017.22.29.30575&partnerID=40&md5=baefc04e70472018551d30cba399452a

33.

Chemtob D, Gandacu D, Mor Z, Grotto I, Anis E, Rosenberg E. A national strategic plan for reducing the burden of sexually transmitted infections in Israel by the year 2025. Israel Journal of Health Policy Research [Internet]. 2017;6(1). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85018487913&doi=10.1186%252fs13584-017-0141-8&partnerID=40&md5=b094dd9ffd48e377f5d798be62a131ae

34.

Tasher D, Kopel E, Anis E, Grossman Z, Somekh E. Causality assessment of serious neurologic adverse events following the bOPV national vaccination campaign in Israel. Israel Medical Association Journal [Internet]. 2016;18(10):590–3. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84994517542&partnerID=40&md5=2413f228bdac0b0e33219fa7f0107093

35.

Glatman-Freedman A, Kaufman Z, Kopel E, Bassal R, Taran D, Valinsky L, et al. Near real-time space-time cluster analysis for detection of enteric disease outbreaks in a community setting. Journal of Infection [Internet]. 2016;73(2):99–106. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84989908628&doi=10.1016%252fj.jinf.2016.04.038&partnerID=40&md5=63555739076c5c409730279f6087ef7d

36.

Tasher D, Rahav G, Levine H, Sofer D, Linder N, Anis E, et al. How many OPV rounds are required to stop wild polio virus circulation in a developed country? Lessons from the Israeli experience. Vaccine [Internet]. 2016;34(3):299–301. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84955382078&doi=10.1016%252fj.vaccine.2015.11.066&partnerID=40&md5=60723e91195923a51d41d4a8c57a9f57

37.

Brosh-Nissimov T, Poles L, Kassirer M, Singer R, Kaliner E, Shriki DD, et al. Preparing for imported ebola cases in israel, 2014 to 2015. Eurosurveillance [Internet]. 2015;20(44). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84947080287&doi=10.2807%252f1560-7917.ES.2015.20.44.30054&partnerID=40&md5=15a041dfda15cccc989bb6d531cfdb0d

38.

Muhsen K, Chodick G, Goren S, Anis E, Ziv-Baran T, Shalev V, et al. Change in incidence of clinic visits for all-cause and rotavirus gastroenteritis in young children following the introduction of universal rotavirus vaccination in Israel. Eurosurveillance [Internet]. 2015;20(42). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84965092103&doi=10.2807%252f1560-7917.ES.2015.20.42.30045&partnerID=40&md5=54c32979152474b8403169bc9d2590a6

39.

Kaliner E, Kopel E, Anis E, Mendelson E, Moran-Gilad J, Shulman LM, et al. The Israeli public health response to wild poliovirus importation. The Lancet Infectious Diseases [Internet]. 2015;15(10):1236–42. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84942196262&doi=10.1016%2fS1473-3099%2815%2900064-X&partnerID=40&md5=8028e7d30b2dd0e26584520e6ba79743

40.

Kalkowska DA, Duintjer Tebbens RJ, Grotto I, Shulman LM, Anis E, Wassilak SGF, et al. Modeling options to manage type 1 wild poliovirus imported into Israel in 2013. Journal of Infectious Diseases [Internet]. 2015;211(11):1800–12. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84930448306&doi=10.1093%252finfdis%252fjiu674&partnerID=40&md5=6dd1ec8ab9e5a26774864071e47c721c

41.

Levine H, Kopel E, Anis E, Givon-Lavi N, Dagan R. The impact of a national routine immunisation programme initiated in 1999 on Hepatitis A incidence in Israel, 1993 to 2012. Eurosurveillance [Internet]. 2015;20(7). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84923280806&doi=10.2807%252f1560-7917.ES2015.20.7.21040&partnerID=40&md5=07a466967001b3a2247a4f6b46d127bf

42.

Kopel E, Grotto I, Grossman T, Haklai Z, Marva E, Anis E. Long-term predictors of recurrent laboratory-confirmed giardiasis: A 10-year national surveillance study. Journal of the Pediatric Infectious Diseases Society [Internet]. 2014;3(4):343–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84949130329&doi=10.1093%252fjpids%252fpiu009&partnerID=40&md5=7fb3528262eb91ba284e9ef34a7e5c6c

43.

Shulman LM, Mendelson E, Anis E, Bassal R, Gdalevich M, Hindiyeh M, et al. Laboratory challenges in response to silent introduction and sustained transmission of wild poliovirus type 1 in Israel during 2013. Journal of Infectious Diseases [Internet]. 2014;210:S304–14. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84910629678&doi=10.1093%252finfdis%252fjiu294&partnerID=40&md5=78df753ff04f203bfe3e8ae8187867a8

44.

Elinav H, Hershko-Klement A, Valinsky L, Jaffe J, Wiseman A, Shimon H, et al. Pregnancy-associated listeriosis: Clinical characteristics and geospatial analysis of a 10-year period in Israel. Clinical Infectious Diseases [Internet]. 2014;59(7):953–61. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84929939328&doi=10.1093%252fcid%252fciu504&partnerID=40&md5=f7e17ef4a1ee6060e763eb5c51ff2537

45.

Gandacu D, Glazer Y, Anis E, Karakis I, Warshavsky B, Slater P, et al. Resurgence of cutaneous leishmaniasis in Israel, 2001-2012. Emerging Infectious Diseases [Internet]. 2014;20(10):1605–11. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84907297297&doi=10.3201%252feid2010.140182&partnerID=40&md5=1874b7832c6bfae34f92bb12b5d9e3a4

46.

Anis E, Grotto I, Mendelson E, Bin H, Orshan L, Gandacu D, et al. West Nile fever in Israel: The reemergence of an endemic disease. Journal of Infection [Internet]. 2014;68(2):170–5. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84892442924&doi=10.1016%252fj.jinf.2013.10.009&partnerID=40&md5=099256d853d278d700bf03806b1a5e24

47.

Moran-Gilad J, Mentasti M, Lazarovitch T, Huberman Z, Stocki T, Sadik C, et al. Molecular epidemiology of Legionnaires’ disease in Israel. Clinical Microbiology and Infection [Internet]. 2014;20(7):690–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84904981685&doi=10.1111%252f1469-0691.12425&partnerID=40&md5=45b37ef248bd4f24194f7664b3822beb

48.

Anis E, Grotto I, Moerman L, Kaliner E, Warshavsky B, Slater PE, et al. Rubella in Israel after the MMR vaccine: Elimination or containment? Journal of Public Health Policy [Internet]. 2013;34(2):288–301. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84877298850&doi=10.1057%252fjphp.2013.8&partnerID=40&md5=600a5dee9c5cbd6988066aede5314bf7

49.

Avidor B, Turner D, Mor Z, Chalom S, Riesenberg K, Shahar E, et al. Transmission Patterns of HIV-Subtypes A/AE versus B: Inferring Risk-Behavior Trends and Treatment-Efficacy Limitations from Viral Genotypic Data Obtained Prior to and during Antiretroviral Therapy. PLoS ONE [Internet]. 2013;8(3). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84874575997&doi=10.1371%252fjournal.pone.0057789&partnerID=40&md5=c999c992dd6983774dd7767ecfef8a24

50.

Ginsberg GM, Eidelman AI, Shinwell E, Anis E, Peyser R, Lotan Y. Should Israel screen all mothers-to-be to prevent early-onset of neonatal group B streptococcal disease? A cost-utility analysis. Israel Journal of Health Policy Research [Internet]. 2013;2(1). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84883507434&doi=10.1186%252f2045-4015-2-6&partnerID=40&md5=6c90275fb709ebc7ddf9cef7b5c658f0

51.

Anis E, Kopel E, Singer SR, Kaliner E, Moerman L, Moran-Gilad J, et al. Insidious reintroduction of wild poliovirus into israel, 2013. Eurosurveillance [Internet]. 2013;18(38). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84884619903&doi=10.2807%252f1560-7917.ES2013.18.38.20586&partnerID=40&md5=8670c649ce393e002b9ac512dec9b191

52.

Levy Y, Anis E, Kaliner E, Grotto I, Danon YL. Estimated size of the population at risk of severe adverse events after smallpox vaccination in Israel. Vaccine [Internet]. 2012;30(47):6632–5. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84867463946&doi=10.1016%252fj.vaccine.2012.08.072&partnerID=40&md5=ee09a53b66a6e263ffacb0b85473f523

53.

Moran-Gilad J, Lazarovitch T, Mentasti M, Harrison T, Weinberger M, Mordish Y, et al. Huhumidifier-associated paediatric legionnaires’ disease, Israel, February 2012. Eurosurveillance [Internet]. 2012;17(41). Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84878445732&partnerID=40&md5=f48b0ef2ee47b6929732ce5907245ffb

54.

Anis E, Grotto I, Moerman L, Warshavsky B, Slater PE, Lev B. Mumps outbreak in Israel’s highly vaccinated society: Are two doses enough? Epidemiology and Infection [Internet]. 2012;140(3):439–46. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84856294997&doi=10.1017%252fS095026881100063X&partnerID=40&md5=b32a1021ef5d3991e1bf1ca509e42774

55.

Engelhard D, Bromberg M, Averbuch D, Tenenbaum A, Goldmann D, Kunin M, et al. Increased extent of and risk factors for pandemic (H1N1) 2009 and seasonal infl uenza among children, Israel. Emerging Infectious Diseases [Internet]. 2011;17(9):1740–3. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-80052179642&doi=10.3201%252feid1709.102022&partnerID=40&md5=86117928b0ed0a2a09c41fd5c7666152

56.

Anis E, Leventhal A, Grotto I, Gandacu D, Warshavsky B, Shimshony A, et al. Recent trends in human brucellosis in Israel. Israel Medical Association Journal [Internet]. 2011;13(6):359–62. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-79960013582&partnerID=40&md5=da26e63076fefeea05c7a04d5c796652

57.

Levy I, Mor Z, Anis E, Maayan S, Leshem E, Pollack S, et al. Men who have sex with men, risk behavior, and HIV infection: Integrative analysis of clinical, epidemiological, and laboratory databases. Clinical Infectious Diseases [Internet]. 2011;52(11):1363–70. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-79957502497&doi=10.1093%252fcid%252fcir244&partnerID=40&md5=cd7308a9dfc4170f0ba3c11a4e5e60b5

58.

Muhsen K, Shohat T, Aboudy Y, Mendelson E, Algor N, Anis E, et al. Sero-prevalence of mumps antibodies in subpopulations subsequently affected: By a large scale mumps epidemic in Israel. Vaccine [Internet]. 2011;29(22):3878–82. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-80051744378&doi=10.1016%252fj.vaccine.2011.03.047&partnerID=40&md5=f14a0db94784dde4832f72d89ccbb2fc

59.

Anis E, Leventhal A, Slater PE, Arbeli Y, Sivan Y, Berlovitz Y, et al. A cluster of deaths following influenza vaccination, Israel, 2006. Journal of Public Health Policy [Internet]. 2010;31(3):318–23. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-77956281730&doi=10.1057%252fjphp.2010.22&partnerID=40&md5=8662d50a97e2f40f8047251c867cfc05

60.

Anis E, Grotto I, Moerman L, Warshavsky B, Slater PE, Lev B, et al. Measles in a highly vaccinated society: The 2007-08 outbreak in Israel. Journal of Infection [Internet]. 2009;59(4):252–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-72149089869&doi=10.1016%252fj.jinf.2009.07.005&partnerID=40&md5=fcfeecdc9ec585af73cc5c947a185d79

61.

Anis E, Leventhal A, Slater PE, Shinar E, Yahalom V, Smetana Z, et al. Smallpox revaccination of 21 000 first responders in Israel: lessons learned. International Journal of Infectious Diseases [Internet]. 2009;13(3):403–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-64649099315&doi=10.1016%252fj.ijid.2008.08.007&partnerID=40&md5=f2b5cfadbe0a13df3597e915b9f473df

62.

Balicer RD, Anis E, Goldmann D, Dahan D, Singer R, Grotto I. Influenza A/H1N1 in Israel–clinical and epidemiological characteristics. Harefuah [Internet]. 2009;148(11):738–42, 795. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-77949909547&partnerID=40&md5=e6bc93ab2153159e9fefb480a9d10e90

63.

Pezzoli L, Elson R, Little CL, Yip H, Fisher I, Yishai R, et al. Packed with Salmonella - Investigation of an international outbreak of Salmonella Senftenberg infection linked to contamination of prepacked Basil in 2007. Foodborne Pathogens and Disease [Internet]. 2008;5(5):661–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-53849107151&doi=10.1089%252ffpd.2008.0103&partnerID=40&md5=7c812ed4ca8fc5c9009b7052fa58ad30

64.

Elinav E, Pinsker G, Safadi R, Pappo O, Bromberg M, Anis E, et al. Association between consumption of Herbalife® nutritional supplements and acute hepatotoxicity. Journal of Hepatology [Internet]. 2007;47(4):514–20. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-34548212844&doi=10.1016%252fj.jhep.2007.06.016&partnerID=40&md5=6f713bca69ca093fd51367d4f771d97a

65.

Moerman L, Leventhal A, Slater PE, Anis E, Yishai R, Marva E. The re-emergence of pertussis in Israel. Israel Medical Association Journal [Internet]. 2006;8(5):308–11. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-33744489316&partnerID=40&md5=b193f8a1be595937cde80581cb0690ad

66.

Dagan R, Leventhal A, Anis E, Slater P, Ashur Y, Shouval D. Incidence of hepatitis A in Israel following universal immunization of toddlers. JAMA [Internet]. 2005;294(2):202–10. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-22144476534&doi=10.1001%252fjama.294.2.202&partnerID=40&md5=8996f3382a07767b0da65028027ece0f

67.

Ben-Ami R, Siegman-Igra Y, Anis E, Brook GJ, Pitlik S, Dan M, et al. Malaria in travelers returning from short organized tours to holiday resorts in Mombassa, Kenya. Israel Medical Association Journal [Internet]. 2005;7(6):364–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-20844433410&partnerID=40&md5=d26a54588b74a5b88ce0acf894046c0f

68.

Sidi G, Davidovitch N, Balicer RD, Anis E, Grotto I, Schwartz E. Tickborne relapsing fever in Israel. Emerging Infectious Diseases [Internet]. 2005;11(11):1784–6. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-27744566973&doi=10.3201%252feid1111.050521&partnerID=40&md5=b004487aab3fe2b7fb82a293c1b9ae97

69.

Anis E, Pener H, Goldmann D, Leventhal A. The reemergence of malaria in Israel? Harefuah [Internet]. 2004;143(11):815–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-16644362712&partnerID=40&md5=5487459ec9d493ef20b256488ac64f34

70.

Ben-Simon GJ, Peiss M, Anis E, Nakra T, Luski A, Spierer A. Spectacle use and reduced unaided vision in third grade students: A comparative study in different educational settings. Clinical and Experimental Optometry [Internet]. 2004;87(3):175–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-3843151656&doi=10.1111%252fj.1444-0938.2004.tb03171.x&partnerID=40&md5=9271e666171a887755861c5922153c13

71.

Green MS, Anis E, Gandacu D, Grotto I. The fall and rise of gonorrhoea incidence in Israel: An international phenomenon? Sexually Transmitted Infections [Internet]. 2003;79(2):116–8. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037392254&doi=10.1136%252fsti.79.2.116&partnerID=40&md5=1a3c22e7d9133dfe483deb969b55f770

72.

Slater PE, Anis E, Leventhal A. Communicable Disease Control: An introductory course for MPH students. Public Health Reviews [Internet]. 2002;30(1–4):327–38. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036982874&partnerID=40&md5=225e7d10cb3b31458cfa496d574c0505

73.

Slater PE, Anis E, Leventhal A. Preparation for an outbreak of smallpox in Israel. Israel Medical Association Journal [Internet]. 2002;4(7):507–12. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036301811&partnerID=40&md5=6eb90b7cef2f4ad213cf5f51529d9d12

74.

Green MS, Aharonowitz G, Shohat T, Levine R, Anis E, Slater PE. The changing epidemiology of viral hepatitis A in Israel. Israel Medical Association Journal [Internet]. 2001;3(5):347–51. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035718418&partnerID=40&md5=0425412fb9636879b2524bac85e6717c

75.

Slater PE, Leventhal A, Anis E. The elimination of smallpox from Israel. Israel Medical Association Journal [Internet]. 2001;3(1):71–2. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035716523&partnerID=40&md5=acd95ce3518c6094e9ed8cd4d9713d51

76.

Anis E, Leventhal A, Elkana Y, Wilamowski A, Pener H. Cutaneous leishmaniasis in Israel in the era of changing environment. Public Health Reviews [Internet]. 2001;29(1):37–47. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0035667208&partnerID=40&md5=fb3499e0efd871b82a7bb0ec9a08c886

77.

Anis E, Leventhal A, Roitman M, Slater PE. Introduction of routine hepatitis A immunization in Israel–the first in the world. Harefuah [Internet]. 2000;138(3):177–80, 272. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0034135759&partnerID=40&md5=661f1aa19c24042a5a0030d548c8c8d4

78.

Aharonowitz G, Koton S, Segal S, Anis E, Green MS. Epidemiological characteristics of spotted fever in Israel over 26 years. Clinical Infectious Diseases [Internet]. 1999;29(5):1321–2. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033504473&doi=10.1086%252f313432&partnerID=40&md5=ff80d0d232fb0b0d081174aea6f1ef68

79.

Slater PE, Anis E, Leventhal A. Measles control in Israel: A decade of the two-dose policy. Public Health Reviews [Internet]. 1999;27(1–3):235–41. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033499295&partnerID=40&md5=f6e247856c23ce2d4c7a996132d3b940

80.

Slater PE, Anis E, Leventhal A. The control of mumps in Israel. European Journal of Epidemiology [Internet]. 1999;15(8):765–7. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032739906&doi=10.1023%252fA%253a1007663429371&partnerID=40&md5=0724fb75489b16e2ef98d1a4028fb2c5

81.

Dagan R, Fraser D, Roitman M, Slater P, Anis E, Ashkenazi S, et al. Effectiveness of a nationwide infant immunization program against Haemophilus influenzae b. Vaccine [Internet]. 1999;17(2):134–41. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0032889629&doi=10.1016%2fS0264-410X%2898%2900165-0&partnerID=40&md5=50b55b4bd34251b5ad8347a0c10a7036

82.

Ostroi P, Anis E, Green MS. Shigellosis in Israel - Update 1995. Public Health Reviews [Internet]. 1996;24(3–4):213–25. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030467511&partnerID=40&md5=9e1a9883d8fdd20e3ad66725bd212db5

83.

Slater PE, Roitman M, Leventhal A, Anis E. Control of rubella in Israel: Progress and challenge. Public Health Reviews [Internet]. 1996;24(2):183–92. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029862577&partnerID=40&md5=b4419bab4c71a5162ee2b9828951a69a

84.

Modan B, Shpilberg O, Anis E, Chetrit A, Luxenburg O, Rosenberg E, et al. The need for liver transplantation: a nationwide estimate based on consensus review. The Lancet [Internet]. 1995;346(8976):660–2. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029100572&doi=10.1016%2fS0140-6736%2895%2992279-2&partnerID=40&md5=843c4a04c003b0dd2d361e5bcf93a7b2

85.

Slater PE, Roitman M, Anis E. Failure of mass chemoprophylaxis to control hyperendemic meningococcal disease. Public health reviews [Internet]. 1995;23(4):367–9. Available from: https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029449406&partnerID=40&md5=53296f4b864fdb6f6984b0d837b34064